THIRD QUARTER 2025 INTERIM MANAGEMENT STATEMENT
Strong third quarter revenue momentum, full year revenue guidance upgraded
5 November 2025 – Glanbia plc, the Better Nutrition company (“Glanbia” or the “Group”), is issuing this Interim Management Statement for the nine month period ended 4 October 2025 (“the period”, or “YTD Q3 2025”).
YTD Q3 2025 Highlights1:
- Group nine-month like-for-like revenue growth of 3.3% with strong growth in the third quarter across all segments;
- Performance Nutrition (“PN”) like-for-like revenue increased by 2.5% excluding SlimFast and Body & Fit;
- Optimum Nutrition like-for-like revenue grew by 4.6% in the period (+14.3% in the third quarter), showing sequential improvement driven by strong volume growth;
- Health & Nutrition (“H&N”) like-for-like revenue growth of 6.1%, driven by strong volume growth;
- Dairy Nutrition (“DN”) like-for-like revenue growth of 6.1%, driven by strong dairy markets;
- €197 million returned to shareholders via share buybacks;
- Continued execution across strategic initiatives including the acquisition of Sweetmix in H&N and completion of the sale of SlimFast and Body & Fit in PN; and
- Capital Markets Day being held in London on 19th November 2025.
Commenting today Hugh McGuire, Chief Executive Officer, said:
“I am pleased to report that Glanbia delivered a good performance during the period, delivering Group like-for-like revenue growth of 3.3% across our portfolio of better nutrition brands and ingredients.
Our Performance Nutrition segment delivered a very strong performance in the third quarter, with our Optimum Nutrition and Isopure brands delivering double digit volume growth. Our Health & Nutrition and Dairy Nutrition segments also continued to perform well, with Health & Nutrition volumes showing strong growth in its priority end-use markets.
We continue to progress our group-wide transformation programme and completed the sale of non-core brands, SlimFast and Body & Fit, as well as the acquisition of Sweetmix in Brazil within our H&N division.
With the third quarter showing strong sequential improvement in Performance Nutrition, we are pleased to upgrade our full year revenue guidance for PN to 3-4% like-for-like revenue growth and now expect our full year adjusted EPS to be in the upper end of the guidance range of 130 $cent - 133 $cent.”
Full results available here
1 On 6 November 2024, Glanbia announced a change in its operating model, separating the Glanbia Nutritionals business into two new divisions, Health & Nutrition (“H&N”) and Dairy Nutrition (“DN”) and from 5 January 2025, Glanbia has reported in line with the revised segment structure. Comparative segment information for the prior year was restated for comparability purposes. The change does not impact total Group or Performance Nutrition revenues or margins. Like-for-like revenue growth excludes the impact of the 53rd week in the prior year and the net impact from acquisitions and disposals and is shown on a constant currency basis.